Company / CapEx per Share
Oric Pharmaceuticals, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.05
FY2021-FY2025
Trend
-52.4%
vs FY2024
Sector context
#129 of 192
Health Care
What the data says
At $0.01, Oric Pharmaceuticals, Inc.'s capex per share ranks #129 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 8 years, ranging from $0.01 in FY2025 to $0.40 in FY2019.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -23.2%.
Declined from $0.02 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -46.3%
- 5-Year CAGR
- -23.2%
- 10-Year CAGR
- -
Sector benchmark
#129 of 192 in Health CareTop 67% of 192This company $0.01 Sector average $3.54
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 52.4% year-over-year.
- Ranks #129 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -52.4% |
| FY2024 | $0.02 | +3.3% |
| FY2023 | $0.02 | -68.5% |
| FY2022 | $0.05 | +111.8% |
| FY2021 | $0.02 | -18.6% |
| FY2020 | $0.03 | -92.5% |
| FY2019 | $0.40 | +33.6% |
| FY2018 | $0.30 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026